Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

18.940
+0.1700.91%
Volume:12.21M
Turnover:230.98M
Market Cap:21.55B
PE:-15.07
High:19.250
Open:18.680
Low:18.650
Close:18.770
52wk High:27.280
52wk Low:12.310
Shares:1.14B
HK Float Shares:1.14B
Volume Ratio:2.44
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.257
ROE:-26.91%
ROA:-14.75%
PB:4.53
PE(LYR):-15.07
PS:6.11

Loading ...

Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
Apr 30

Zai Lab hits 286,000 new patients in 2025, keeps gender-pay parity and readies first global launch for 2028

Bulletin Express
·
Apr 28

再鼎医药2025年营收同比增长15.3%,全球业务与管线稳步扩张

Bulletin Express
·
Apr 28

Zai Lab publishes 2025 annual report

Reuters
·
Apr 28

ZAI LAB Calls 2026 AGM; Seeks Shareholder Nod on Director Re-election, KPMG Appointment and 10% Share Issuance/Buyback Mandates

Bulletin Express
·
Apr 28

Zai Lab announces annual shareholder meeting

Reuters
·
Apr 28

Zai Lab Sets 17 June 2026 AGM; Nine Director Re-elections, KPMG Appointment and 10% Share Mandates on Agenda

Bulletin Express
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Apr 23

Zai Lab to Review and Publish Q1 2026 Results on 7 May; Earnings Call Scheduled Same Day

Bulletin Express
·
Apr 23

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23

Zai Lab to report first-quarter results, host conference call

Reuters
·
Apr 22

Zai Lab publishes AACR presentation highlighting DLL3 ADC ZL-1310 in SCLC brain metastases

Reuters
·
Apr 20

Zai Lab Shares Climb Over 5% on Positive Preclinical Data for ZL-1503

Stock News
·
Apr 20

Stock Track | Zai Lab Soars 5.25% Intraday on Clinical Collaboration with Boehringer Ingelheim

Stock Track
·
Apr 20

Zai Lab starts Phase 1/1b trial of ZL-1503 bispecific antibody in atopic dermatitis

Reuters
·
Apr 18

Zai Lab says zoci posts 53.7% intracranial response rate in SCLC brain metastases trial

Reuters
·
Apr 18

Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer With Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas

THOMSON REUTERS
·
Apr 18

Zai Lab announces annual shareholder meeting

Reuters
·
Apr 17

Stock Track | Zai Lab Soars 5.05% Intraday on Clinical Collaboration with Boehringer Ingelheim for Novel Cancer Therapy

Stock Track
·
Apr 16